2024/07/04 AD Regulation
Drug Master File system of China (Part 2)
Chapter 2 How to file DMF in China? I have introduced something about the background, basic requirements of China DMF system in the previous article.
2024/06/17 AD Regulation
Drug Master File system of China (Part 1)
Chapter 1 Introduction on Bundling review Regulation in China 1. Introduction Since China drug regulation reform from 2015, China Food and Drug Adm
2024/03/13 AD Regulation
China NMPA’s observations of ‘flight inspection’ on medical devices
In 2023, the China NMPA(National Medical Products Administration) conducted ‘flight inspections’ (unannounced inspections) to 20 medical d
2025/10/23 AD Quality System
What the Revised GMP Ministerial Ordinance changed.
On Establishing the Required Structure for a Modern QA Department [Part 2]
2025/08/06 AD Quality System
Fact from 2,500 of FDA Form 483s
Data Integrity Issue Trend on FDA Inspections
2025/09/03 AD Quality System
On Establishing the Required Structure for a Modern QA Department [Part 1]
2025/05/15 AD
Deficiencies in multi-purpose manufacturing site
PMDA ORANGE LETTER_2025.01
2025/11/14 AD
Deficiency in Sterility Assurance by Sterilization Validation
PMDA ORANGE LETTER_2025.08
2025/08/05 AD
Problems Behind Discrepancies with product authorization requirements
PMDA ORANGE LETTER_2025.05
2025/07/15 AD
PMDA ORANGE LETTER_2025.03
2025/01/23 AD
Findings related to discrepancies with approved dossier and fake record
PMDA ORANGE LETTER_2024.10
AD
医薬品の技術移転のポイント【第3回】
Morio Wakisaka
Ryoichi Tanaka
You will be navigated to the CM Plus company website.
CM Plus Group Website